Carpmaels & Ransford LLP

Carpmaels & Ransford is pleased to welcome two new litigation partners Niels Hölder and Mike Gruber, as the firm significantly expands its presence in Germany to meet demand for the firm's contentious services in Europe, particularly at the Unified Patent Court (UPC). This strategic growth includes the relocation of Carpmaels’ Germany office to a larger site in the centre of Munich which will accommodate an expanding team of German attorneys, litigators and support services. Mike joins the firm on 1st September 2025, with Niels arriving on 1st January 2026. Niels and Mike have both worked with Carpmaels & Ransford for several years, including on the case of Sanofi v Amgen, the first ever UPC revocation action. Mike, formerly of Hoffmann Eitle, is an established litigator experienced in international patent disputes with a particular focus on the life sciences sector. Mike has over ten years’ experience in litigating and resolving cases before the German patent and appeal courts and more recently the UPC. He often advises on matters that cross both the Atlantic and into continental Europe. Partner and Head of Dispute Resolution Ian Kirby says, "Our expansion in Germany marks the next phase in the growth of our litigation practice. Since founding the team in 2014, our vision has been to build a truly integrated practice which could handle parallel disputes in the EPO, UPC and UK courts, while coordinating national actions across Europe. Although the landscape has changed significantly since then, we have remained committed to developing a deep and talented bench of EPO advocates and European litigators focused on UPC work. We filed the first ever UPC revocation action and demand for our UPC services continues to grow.” Senior Partner Hugh Goodfellow comments, “We are very pleased to welcome Niels and Mike to the partnership having worked collaboratively with them on significant cases for many years. They will play an important role in our growing European capability, at a time when clients are increasingly looking to us for contentious services at the UPC, as well as in European and global matters.” “Niels and Mike will be a valuable addition to the Munich office. Their experience in complex life sciences litigation, combined with deep technical expertise will be invaluable to our clients,” says Partner and Head of the Munich Office Stephen Duffield. Commenting on his arrival, Partner Mike Gruber says, “I’m excited to be joining Carpmaels at a pivotal time for the firm’s growth in Germany. I look forward to working with the team to assist our healthcare clients with strategic cross-border litigation including at the UPC.” Niels and Mike are the latest additions to Carpmaels & Ransford’s rapidly growing litigation team following the arrival of Partner Andrew Hutchinson on 1st July 2025, Counsel Alexandra Pearson on 21st July 2025, Senior Associate Delicia Clarke on 1st September, as well as several associates in recent months. The litigation team now includes Dutch, French and German litigators, enabling the firm to staff UPC matters with creative diverse teams. More than 40 Carpmaels attorneys are deeply involved in active UPC litigation and many more in UPC related advice. In total the firm has more than 90 qualified UPC representatives and over 20 litigators with experience of national and UPC litigation. About Carpmaels & Ransford LLP The firm is a leader in the European IP market, having driven innovation in the industry for over 200 years. From our offices in London, Munich, and Dublin, we manage many of the world’s leading IP portfolios, including those protecting our clients’ most commercially valuable products and services. Carpmaels & Ransford provides a holistic service to clients which supports their IP needs at every stage of growth. With our deep bench of patent attorneys and fully integrated Dispute Resolution, Transactions and Trade Marks teams, we have worked with many of our clients from inception through to becoming market leaders. Media contacts: Susie Pugsley, Director of Marketing & BD e: [email protected] T: +44 20 7242 8692 Clare Gilbey, Communications Manager e: [email protected] T: +44 20 7242 8692

Russell Woolley joins the partnership on 1st July 2025   Carpmaels & Ransford is pleased to announce the promotion of Russell Woolley to the partnership effective from 1st July 2025. Russell sits within the firm’s Chemistry team. Building on his academic experience and PhD researching fuel cell electrodes, Russell has built up particular expertise in the field of energy storage and conversion, including lithium-ion batteries. He works for firms big and small, from established industry players to guiding start-ups with their first few patent applications. His work stands up to scrutiny: Russell’s clients have secured major investment following in-depth due diligence assessing the strengths of portfolios he has drafted and prosecuted. Russell is a leading member of the Carpmaels multidisciplinary Energy+ team made up of attorneys with expertise across chemistry, materials, electro-mechanical engineering, IT, and biochemistry. The team enjoys devising creative strategies for high-value IP assets in the rapidly developing and exciting energy field, leveraging their technical know-how and extensive experience handling contentious matters and coordinating global portfolios. Hugh Goodfellow, Managing Partner at Carpmaels & Ransford, comments: “Russell has developed an impressive practice during his time at the firm, and we are very pleased that he is joining the partnership. His promotion will further strengthen our growing energy team and the work we do advising clients across the full spectrum of new technology in the energy sector.”

Carpmaels & Ransford is pleased to announce Selina Badiani, Harry Bush, Emily Chittock, Henry Evans and Rebecca Satchwell have been promoted to Senior Associate positions effective from 1st January 2025. Harry Bush and Rebecca Satchwell both trained at the firm and are patent attorneys in the Chemistry team. Harry advises a variety of clients, focussing on small molecule pharmaceuticals. He works on all aspects of the lifespan of a patent, with experience focussing on drafting new applications, patent prosecution at the EPO and globally, and EPO oppositions. Rebecca handles a variety of subject-matter ranging from NCEs and medical uses, formulations and polymorphs to consumer products and medical devices. She has experience across the patent lifespan, from prosecution through opposition, SPC applications and litigation (both in Europe and further afield), and has put this knowledge to good use in defence of patent portfolios for several blockbuster pharmaceuticals. Emily Chittock and Henry Evans also trained at the firm and are patent attorneys in the Life Sciences team. Emily specialises in nucleic acid and protein therapeutics, and in platform and manufacturing technologies. She has particular experience in multi-party EPO opposition and appeal work and in coordinating prosecution of European and global patent portfolios. Henry has a diverse portfolio of work spanning immune-oncology, advanced single-cell sequencing technology, and biologics. His practice focuses on EPO opposition/appeal work with large EPO prosecution and SPC portfolios. He has also recently been involved in two significant UPC cases handled by Carpmaels & Ransford. Selina Badiani is a solicitor and a member of the Dispute Resolution team, primarily focussing on patent litigation cases involving both small molecule drugs and biologics in the life sciences sector. She joined the firm in August 2021, having qualified as a solicitor in 2019. Selina has experience of litigation in the High Court and Supreme Court of the UK, and has also worked on large coordination projects, involving litigation in multiple European jurisdictions. Hugh Goodfellow, Managing Partner at Carpmaels & Ransford, said: “We’ve seen a great period of senior growth for the firm recently, which has further strengthened our impressive litigation capabilities and the services we provide to our healthcare focused clients. I’m looking forward to seeing our new Senior Associates thrive in their roles as they bring great value to their clients and respective sectors.”